Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0155 | 0.0155 |
Echinococcus granulosus | GPCR family 2 | 0.0184 | 0.2937 | 0.7153 |
Brugia malayi | hypothetical protein | 0.0032 | 0.0232 | 0.0232 |
Schistosoma mansoni | tar DNA-binding protein | 0.025 | 0.4107 | 0.6101 |
Brugia malayi | MH2 domain containing protein | 0.0494 | 0.8431 | 0.8431 |
Brugia malayi | Smad1 | 0.0034 | 0.0265 | 0.0265 |
Echinococcus multilocularis | nibrin | 0.0032 | 0.0232 | 0.0565 |
Brugia malayi | MH1 domain containing protein | 0.0034 | 0.0265 | 0.0265 |
Wolbachia endosymbiont of Brugia malayi | NAD-dependent DNA ligase, Lig | 0.0032 | 0.0232 | 0.5 |
Brugia malayi | DKFZp564C0469 protein | 0.0032 | 0.0232 | 0.0232 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0032 | 0.0232 | 0.5 |
Trypanosoma cruzi | FHA domain containing protein, putative | 0.0032 | 0.0232 | 1 |
Schistosoma mansoni | DNA ligase IV | 0.0032 | 0.0232 | 0.0345 |
Loa Loa (eye worm) | Smad1 | 0.0034 | 0.0265 | 0.0265 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0232 | 0.0232 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0184 | 0.2937 | 0.7153 |
Echinococcus granulosus | nibrin | 0.0032 | 0.0232 | 0.0565 |
Giardia lamblia | Replication factor C, subunit 1 | 0.0032 | 0.0232 | 0.5 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0032 | 0.0232 | 0.5 |
Mycobacterium ulcerans | NAD-dependent DNA ligase LigA | 0.0032 | 0.0232 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0232 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 0.2937 | 0.4364 |
Plasmodium vivax | replication factor C subunit 1, putative | 0.0032 | 0.0232 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0399 | 0.6731 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.0155 | 0.6693 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0155 | 0.6693 |
Echinococcus granulosus | smad | 0.0034 | 0.0265 | 0.0647 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.0155 | 1 |
Schistosoma mansoni | topbp1 | 0.0032 | 0.0232 | 0.0345 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0232 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0184 | 0.2937 | 0.2937 |
Treponema pallidum | DNA ligase (lig) | 0.0032 | 0.0232 | 0.5 |
Schistosoma mansoni | smad1 5 8 and | 0.0034 | 0.0265 | 0.0394 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.0155 | 0.6693 |
Onchocerca volvulus | 0.0032 | 0.0232 | 0.5 | |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.025 | 0.4107 | 0.4107 |
Entamoeba histolytica | hypothetical protein | 0.0032 | 0.0232 | 0.5 |
Entamoeba histolytica | Activator 1 140 kDa subunit, putative | 0.0032 | 0.0232 | 0.5 |
Toxoplasma gondii | ATPase, AAA family protein | 0.0032 | 0.0232 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0155 | 0.6693 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0583 | 1 | 1 |
Schistosoma mansoni | smad | 0.0034 | 0.0265 | 0.0394 |
Schistosoma mansoni | smad1 5 8 and | 0.0034 | 0.0265 | 0.0394 |
Echinococcus multilocularis | smad | 0.0034 | 0.0265 | 0.0647 |
Loa Loa (eye worm) | TAR-binding protein | 0.025 | 0.4107 | 0.4107 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0032 | 0.0232 | 1 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0034 | 0.0265 | 0.0647 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0027 | 0.0155 | 0.6693 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0034 | 0.0265 | 0.0647 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0184 | 0.2937 | 0.2937 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0155 | 0.6693 |
Echinococcus granulosus | replication factor c subunit 1 | 0.0032 | 0.0232 | 0.0565 |
Echinococcus granulosus | tar DNA binding protein | 0.025 | 0.4107 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0034 | 0.0265 | 0.0265 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0583 | 1 | 1 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0034 | 0.0265 | 0.0647 |
Echinococcus multilocularis | Smad4 | 0.0034 | 0.0265 | 0.0647 |
Brugia malayi | Pax transcription activation domain interacting protein | 0.0032 | 0.0232 | 0.0232 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0494 | 0.8431 | 0.8431 |
Brugia malayi | MH1 domain containing protein | 0.0034 | 0.0265 | 0.0265 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0232 | 0.0232 |
Brugia malayi | ATP dependent DNA ligase C terminal region family protein | 0.0032 | 0.0232 | 0.0232 |
Echinococcus multilocularis | GPCR, family 2 | 0.0184 | 0.2937 | 0.7153 |
Schistosoma mansoni | Smad4 | 0.0034 | 0.0265 | 0.0394 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 0.2937 | 0.4364 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.2937 | 0.2937 |
Schistosoma mansoni | tar DNA-binding protein | 0.025 | 0.4107 | 0.6101 |
Echinococcus multilocularis | tar DNA binding protein | 0.025 | 0.4107 | 1 |
Brugia malayi | topoisomerase | 0.0032 | 0.0232 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0232 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.0399 | 0.6731 | 0.6731 |
Brugia malayi | RNA binding protein | 0.025 | 0.4107 | 0.4107 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0184 | 0.2937 | 0.7153 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0232 | 0.0232 |
Mycobacterium leprae | PROBABLE DNA LIGASE [NAD DEPENDENT] LIGA (POLYDEOXYRIBONUCLEOTIDE SYNTHASE [NAD+]) | 0.0032 | 0.0232 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0232 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0034 | 0.0265 | 0.0265 |
Schistosoma mansoni | topbp1 | 0.0032 | 0.0232 | 0.0345 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0155 | 0.6693 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0232 | 0.0232 |
Trichomonas vaginalis | RNA polymerase II ctd phosphatase, putative | 0.0032 | 0.0232 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.025 | 0.4107 | 0.4107 |
Chlamydia trachomatis | DNA ligase | 0.0032 | 0.0232 | 0.5 |
Trichomonas vaginalis | RNA polymerase II ctd phosphatase, putative | 0.0032 | 0.0232 | 0.5 |
Trichomonas vaginalis | replication factor C large subunit, putative | 0.0032 | 0.0232 | 0.5 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0034 | 0.0265 | 0.0647 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0032 | 0.0232 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 0.2937 | 0.4364 |
Echinococcus granulosus | Smad4 | 0.0034 | 0.0265 | 0.0647 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0155 | 0.0155 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0494 | 0.8431 | 0.8431 |
Schistosoma mansoni | tar DNA-binding protein | 0.025 | 0.4107 | 0.6101 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0184 | 0.2937 | 0.2937 |
Brugia malayi | TAR-binding protein | 0.025 | 0.4107 | 0.4107 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0034 | 0.0265 | 0.0394 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0184 | 0.2937 | 0.7153 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0184 | 0.2937 | 0.7153 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 0.2937 | 0.4364 |
Plasmodium falciparum | replication factor C subunit 1, putative | 0.0032 | 0.0232 | 1 |
Toxoplasma gondii | poly(ADP-ribose) polymerase catalytic domain-containing protein | 0.0032 | 0.0232 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0232 | 0.5 |
Trypanosoma brucei | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0032 | 0.0232 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.0034 | 0.0265 | 0.0394 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0034 | 0.0265 | 0.0265 |
Brugia malayi | hypothetical protein | 0.0032 | 0.0232 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0232 | 0.0232 |
Echinococcus multilocularis | replication factor c subunit 1 | 0.0032 | 0.0232 | 0.0565 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0399 | 0.6731 | 0.6731 |
Loa Loa (eye worm) | hypothetical protein | 0.0583 | 1 | 1 |
Trypanosoma cruzi | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0032 | 0.0232 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0034 | 0.0265 | 0.0265 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0232 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.025 | 0.4107 | 0.4107 |
Schistosoma mansoni | chromosome transmission fidelity factor | 0.0032 | 0.0232 | 0.0345 |
Schistosoma mansoni | tar DNA-binding protein | 0.025 | 0.4107 | 0.6101 |
Schistosoma mansoni | tar DNA-binding protein | 0.025 | 0.4107 | 0.6101 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ILS (ADMET) | 0 % | In vivo activity of the compound was determined against mice infected with murine p388 lymphocytic leukemia cells at a ip dose of 0.8 mg/kg; Toxic | ChEMBL. | No reference |
ILS (ADMET) | 0 % | In vivo activity of the compound was determined against mice infected with mice infected with murine p388 lymphocytic leukemia cells at a ip dose of 0.4 mg/kg; Toxic | ChEMBL. | No reference |
ILS (functional) | < 20 % | In vivo activity of the compound was determined against mice infected with murine p388 lymphocytic leukemia cells at a ip dose of 0.05 mg/kg | ChEMBL. | No reference |
ILS (functional) | < 20 % | In vivo activity of the compound was determined against mice infected with murine p388 lymphocytic leukemia cells at a ip dose of 0.05 mg/kg | ChEMBL. | No reference |
ILS (functional) | = 60 % | In vivo activity of the compound was determined against mice infected with murine p388 lymphocytic leukemia cells at a ip dose of 0.1 mg/kg | ChEMBL. | No reference |
ILS (functional) | = 60 % | In vivo activity of the compound was determined against mice infected with murine p388 lymphocytic leukemia cells at a ip dose of 0.1 mg/kg | ChEMBL. | No reference |
ILS (functional) | = 73 % | In vivo activity of the compound was determined against mice infected with murine p388 lymphocytic leukemia cells at a ip dose of 0.2 mg/kg | ChEMBL. | No reference |
ILS (functional) | = 73 % | In vivo activity of the compound was determined against mice infected with murine p388 lymphocytic leukemia cells at a ip dose of 0.2 mg/kg | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.